This week, members of our Coalition are attending an exciting workshop; 'Introduction to Costing' in collaboration with UNICEF South Africa. We hope to continue to empower our members and civil society partners to deepen their knowledge and budget advocacy skills.

#Budget2024 #Costing

Domestic Resource Mobilization and Achieving Sustainable Health Financing in Africa CWGH-Zimbabwe WACI Health The Global Fund Peter Sands SAHTACtweets Ministry of HealthZW GFAN Africa #MeetTheTarget

This just in!!! 📰 💉

Gavi’s Board just approved the African Vaccine Manufacturing Accelerator – a $1 billion initiative to boost sustainable vaccine manufacturing in Africa. bit.ly/47LBUjm

We celebrate this step toward a healthier, more resilient 🌍! #VaccineAlliance

CPHIA 2023: CLOSING CEREMONY| NOV. 30, 2023 twitter.com/i/broadcasts/1…

As we close #CPHIA2023 , we are reminded of the words from HE Dr Jean Kaseya, Director General, Africa CDC. “Local Manufacturing will be the second independence of Africa.”

CPHIA Official CHReaD SAHTACtweets Only 10 of the new antibiotics that entered the market between 1999 and 2014 were registered on more than 10 countries. 😫
CPHIA Official
#AntimicrobialResistance

The Africa CDC celebrates Tedros Adhanom Ghebreyesus Director-General of World Health Organization (WHO) on his Lifetime Achievement Award in Public Health.
This award is testimony to Dr Tedros's commitment to ensuring access to healthcare, promoting equity, and tackling emerging health threats that has left an indelible…

As leaders gather at #CPHIA2023 , 30+ African CSOs call for African leaders to commit to PANDEMIC ACTION 💥🌍

TOGETHER we can build a more resilient, inclusive, and equitable public health system in Africa! 🙌🏿🙌🏾🙌🏽

CALL TO ACTION! pandemicactionnetwork.org/news/agenda-fo…

Watch: Chimwemwe Chamdimba, Principal Policy Specialist for AUDA-NEPAD provides insights into African independence through AMA and capacity building. #CPHIA2023

Chimwemwe Chamidimba from AUDA: As AMA comes into force, we want global procures to take the processes that AMA has put in place and ensure medicines manufactured in Africa are part of those procured.
CPHIA Official
SAHTACtweets
CHReaD

Skhumbuzo Ngozwana, CEO Kiara Health: We are almost at the 1 billionth TLD drug for HIV. Most of that drug is produced outside Africa but most is consumed in Africa. 1/2
CPHIA Official
CHReaD
SAHTACtweets

“As we advocate for African Medicines Agency (AMA) we need to do the same for Market Access.” - Dr Skhumbuzo Ngozwana, CEO of KIARA. #CPHIA2023

In her discussion on patient groups, Prof Amany El-Sharif
VP of PanAfricanUniversity concluded that AMA presents a unique opportunity patient groups to engage with the regulatory process. #CPHIA2023

Tiwadayo Braimoh, MedicinesPatentPool Policy & Advocacy Manager talked through what a fully operational AMA could mean for access to the affordable versions of innovative medicines. #CPHIA2023

This disparity in the drug review process is costly for manufacturers and is a disincentive access in the continent. The Africa Medicines Agency can resolve this. 2/2
CPHIA Official
SAHTACtweets
CHReaD

A recent study found that it takes years for a product that has been approved by the FDA to go from submission to approval ranges from less than 1 year to 5 years. 1/2
CPHIA Official
SAHTACtweets
CHReaD

Shakwei CPHIA Official SAHTACtweets Great insights indeed in demystifying AMA MedicinesPatentPool SAHTACtweets Pandemic Action Network

Tiwadayo Braimoh of Medicines Patent Pool: Only about 40% of medicines ever discovered make it to Africa due to the costs involved. This must change.
CPHIA Official
CHReaD
SAHTACtweets

Watch: Aurum Managing Director for Implementation Research discusses the economic pros to the ratification of AMA. #CPHIA2023

“This event is strongly connected to the common theme of #CPHIA2023 . And that is for Africa to have its own capacity to manufacture their own pharmaceutical products.” - Global Health Advocate, Evelyn Kibuchi in opening of the Illuminating AMA Ratification side event.